Dr Avinash Desai becomes VP, Americas Oncology Medical Affairs, Oncology Business Group at Eisai Inc

Desai has more than 20 years of experience in the oncology field

Dr Avinash Desai

Eisai Inc, the US pharmaceutical subsidiary of Eisai of Japan, has appointed Avinash Desai as Vice President, Americas Oncology Medical Affairs for the Oncology Business Group (OBG).

In this role, Desai will lead Eisai's Oncology Medical Affairs team by creating and overseeing the medical strategy for the Oncology Commercial and Market Access businesses in the Americas. Desai, who has more than 20 years of experience in the oncology field, will work with the company's clinical, commercial and OBG strategy organisations to develop, implement and deliver oncology life cycle plans.

Desai joins Eisai from Janssen Pharmaceuticals, where he was Global Medical Affairs Leader, Oncology responsible for leading the life cycle management of the company's oncology/haematology products.

Prior to Janssen, he was Director, International Clinical Development Oncology at Sanofi-Aventis. Desai also led the oncology clinical research/medical affairs department at Genaera.

Companies